PCDH8 inhibits glioma cell proliferation by negatively regulating the AKT/GSK3β/β‑catenin signaling pathway

Zong,Zhenkun; Pang,Hui; Yu,Rutong; Jiao,Yunqi

doi:10.3892/ol.2017.6629

PCDH8 inhibits glioma cell proliferation by negatively regulating the AKT/GSK3β/β‑catenin signaling pathway

Authors:
- Zhenkun Zong
- Hui Pang
- Rutong Yu
- Yunqi Jiao
View Affiliations

Affiliations: Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221002, P.R. China, Department of Cardiovascular Medicine, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University, Affiliated Xuzhou Hospital of Medical College of Southeast University, Xuzhou, Jiangsu 221009, P.R. China
Published online on: July 20, 2017 https://doi.org/10.3892/ol.2017.6629
Pages: 3357-3362
Copyright: © Zong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Protocadherin‑8 (PCDH8), a member of the protocadherin superfamily of proteins, is frequently lost in numerous types of cancer. However, the role that PCDH8 serves in human glioma, and the molecular mechanisms underlying this, remain unclear. Data from the present study demonstrated that the expression levels of PCDH8 mRNA and protein were significantly decreased in human glioma tissue compared with normal brain tissue. This suggested that PCDH8 is associated with the development of glioma. Thus, the role of PCDH8 in glioma cell proliferation was investigated by silencing and overexpressing PCDH8 in U251 glioma cells. Overexpression of PCDH8 significantly inhibited glioma cell proliferation, while silencing of PCDH8 using small interfering RNA promoted glioma cell proliferation. Restoration of PCDH8 decreased phosphorylated (p)‑Rac‑α serine/threonine‑protein kinase (AKT) [Threonine (T)308/Serine (S)473] and p‑glycogen synthase kinase‑3β (p‑GSK3β) (S9) protein expression, thereby reducing the level of β‑catenin when compared with the control. By contrast, silencing of PCDH8 increased levels of p‑AKT (T308/S473) and p‑GSK3β (S9), thereby increasing the level of β‑catenin. In conclusion, the results of the present study suggested that PCDH8 suppressed glioma cell proliferation, and that the loss of PCDH8 may stimulate the proto‑oncogene Wnt/β‑catenin signaling pathway and therefore promote glioma cell proliferation.

View Figures

View References

1	Meyer MA: Malignant gliomas in adults. N Engl J Med. 359:18502008. View Article : Google Scholar : PubMed/NCBI
2	Buonerba C, Di Lorenzo G, Marinelli A, Federico P, Palmieri G, Imbimbo M, Conti P, Peluso G, De Placido S and Sampson JH: A comprehensive outlook on intracerebral therapy of malignant gliomas. Crit Rev Oncol Hematol. 80:54–68. 2011. View Article : Google Scholar : PubMed/NCBI
3	Sherman JH, Hoes K, Marcus J, Komotar RJ, Brennan CW and Gutin PH: Neurosurgery for brain tumors: Update on recent technical advances. Curr Neurol Neurosci Rep. 11:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
4	Fiorentino A, Chiumento C, Caivano R, Cozzolino M, Pedicini P and Fusco V: Adjuvant radiochemotherapy in the elderly affected by glioblastoma: Single-institution experience and literature review. Radiol Med. 118:870–881. 2013.(In Italian). View Article : Google Scholar : PubMed/NCBI
5	Kim SY, Yasuda S, Tanaka H, Yamagata K and Kim H: Non-clustered protocadherin. Cell Adh Migr. 5:97–105. 2011. View Article : Google Scholar : PubMed/NCBI
6	Sano K, Tanihara H, Heimark RL, Obata S, Davidson M, St John T, Taketani S and Suzuki S: Protocadherins: A large family of cadherin-related molecules in central nervous system. EMBO J. 12:2249–2256. 1993.PubMed/NCBI
7	Frank M and Kemler R: Protocadherins. Curr Opin Cell Biol. 14:557–562. 2002. View Article : Google Scholar : PubMed/NCBI
8	Phillips GR, Tanaka H, Frank M, Elste A, Fidler L, Benson DL and Colman DR: Gamma-protocadherins are targeted to subsets of synapses and intracellular organelles in neurons. J Neurosci. 23:5096–5104. 2003.PubMed/NCBI
9	Kim SY, Chung HS, Sun W and Kim H: Spatiotemporal expression pattern of non-clustered protocadherin family members in the developing rat brain. Neuroscience. 147:996–1021. 2007. View Article : Google Scholar : PubMed/NCBI
10	Okazaki N, Takahashi N, Kojima S, Masuho Y and Koga H: Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Carcinogenesis. 23:1139–1148. 2002. View Article : Google Scholar : PubMed/NCBI
11	Stassar MJ, Devitt G, Brosius M, Rinnab L, Prang J, Schradin T, Simon J, Petersen S, Kopp-Schneider A and Zöller M: Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer. 85:1372–1382. 2001. View Article : Google Scholar : PubMed/NCBI
12	Chen MW, Vacherot F, De La Taille A, Gil-Diez-De-Medina S, Shen R, Friedman RA, Burchardt M, Chopin DK and Buttyan R: The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells. Oncogene. 21:7861–7871. 2002. View Article : Google Scholar : PubMed/NCBI
13	Waha A, Güntner S, Huang TH, Yan PS, Arslan B, Pietsch T, Wiestler OD and Waha A: Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas. Neoplasia. 7:193–199. 2005. View Article : Google Scholar : PubMed/NCBI
14	Imoto I, Izumi H, Yokoi S, Hosoda H, Shibata T, Hosoda F, Ohki M, Hirohashi S and Inazawa J: Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers. Cancer Res. 66:4617–4626. 2006. View Article : Google Scholar : PubMed/NCBI
15	Ying J, Li H, Seng TJ, Langford C, Srivastava G, Tsao SW, Putti T, Murray P, Chan AT and Tao Q: Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene. 25:1070–1080. 2006. View Article : Google Scholar : PubMed/NCBI
16	Yu JS, Koujak S, Nagase S, Li CM, Su T, Wang X, Keniry M, Memeo L, Rojtman A, Mansukhani M, et al: PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer. Oncogene. 27:4657–4665. 2008. View Article : Google Scholar : PubMed/NCBI
17	Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, Tian LW, Wong YP, Tong JH, Ying JM, et al: Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer. Gastroenterology. 136:640–651, e1. 2009. View Article : Google Scholar : PubMed/NCBI
18	Strehl S, Glatt K, Liu QM, Glatt H and Lalande M: Characterization of two novel protocadherins (PCDH8 and PCDH9) localized on human chromosome 13 and mouse chromosome 14. Genomics. 53:81–89. 1998. View Article : Google Scholar : PubMed/NCBI
19	He D, Zeng Q, Ren G, Xiang T, Qian Y, Hu Q, Zhu J, Hong S and Hu G: Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma. Eur J Cancer Prev. 21:569–575. 2012. View Article : Google Scholar : PubMed/NCBI
20	Zhang D, Zhao W, Liao X, Bi T, Li H and Che X: Frequent silencing of protocadherin 8 by promoter methylation, a candidate tumor suppressor for human gastric cancer. Oncol Rep. 28:1785–1791. 2012.PubMed/NCBI
21	Lin YL, Ma JH, Luo XL, Guan TY and Li ZG: Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer. J Int Med Res. 41:48–54. 2013. View Article : Google Scholar : PubMed/NCBI
22	Lin YL, Wang YL, Ma JG and Li WP: Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer. J Exp Clin Cancer Res. 33:682014. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Xu Y, Yang Z, Yuan H, Li Z, Li Y, Liu Q and Chen J: PCDH10 inhibits cell proliferation of multiple myeloma via the negative regulation of the Wnt/β-catenin/BCL-9 signaling pathway. Oncol Rep. 34:747–754. 2015.PubMed/NCBI
25	Ge X and Wang X: Role of Wnt canonical pathway in hematological malignancies. J Hematol Oncol. 3:332010. View Article : Google Scholar : PubMed/NCBI
26	Liu YZ, Wu K, Huang J, Liu Y, Wang X, Meng ZJ, Yuan SX, Wang DX, Luo JY, Zuo GW, et al: The PTEN/PI3K/Akt and Wnt/β-catenin signaling pathways are involved in the inhibitory effect of resveratrol on human colon cancer cell proliferation. Int J Oncol. 45:104–112. 2014.PubMed/NCBI